Cardiovascular diseases - improved prediction, prevention, diagnosis, and monitoring
The HORIZON-JU-IHI-2022-02-01 program aimed to significantly advance the prediction, prevention, diagnosis, and monitoring of cardiovascular diseases. This initiative focused on integrating diverse patient data and cutting-edge technologies like AI to develop personalized risk assessment and treatment strategies. It fostered cross-sectoral collaboration to translate health research into tangible benefits for patients and society.
Who is Funded: Eligible Participants and Program Goals
This section outlines the target audience for the program, including eligible organizations, the geographical areas where projects can be implemented, and the overarching goals the funding aims to achieve. It specifies that a wide array of entities across Europe and associated countries are encouraged to participate in collaborative efforts to address cardiovascular health challenges.
What is Funded: Project Focus and Scope
This section details the specific types of projects and activities eligible for funding, focusing on the thematic areas of support and the typical developmental stage of projects. It highlights the program's commitment to advancing innovations in cardiovascular health through targeted research and development efforts.
Type and Scope of Funding: Financial Overview
This section outlines the financial mechanisms and scope of support available under the program, detailing the type of financial instrument, the maximum funding available per project, and general financial parameters.
Conditions and Requirements for Applicants
This section details the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to throughout the application and project implementation phases. It covers various stipulations, including consortium requirements and other significant provisions.
Application and Selection Procedure
This section provides a clear overview of the application and selection processes, detailing the steps for proposal submission and how applications are evaluated to determine successful projects.
Legal Framework and Governing Documents
This section identifies the foundational legal and official documents that establish and govern the program, providing insight into its legitimacy and the broader regulatory framework within which it operates.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
11.179.000 €
Allocated Budget:
11.179.000 €
Deadline:
28.02.2023
Award Channel:
Framework Programme Call
Region:
European Union
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Information and Communication Technology, Software Development
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Product Development, Pilot Testing, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Union, Innovative Health Initiative Joint Undertaking (IHI JU)
Managed By:
Innovative Health Initiative Joint Undertaking (IHI JU)
Additional Partners:
NanoSciTec GmbH, Green NanoTech, SMARTEX s.r.l., UDRUZENJE - KLASTER MEDICINSKOG I ZDRAVSTVENOG TURIZMA, ASOCIATIA DE STANDARDIZARE DIN ROMANIA, LIONEX GMBH, C4G - CONSULTING AND TRAINING NETWORK, LDA, SYNLAB International GmbH, MediSensonic Sp. z o.o., MEDIC4ALL ITALIA S.R.L., UNIVERSITA DEGLI STUDI DI FIRENZE, SYNYO GmbH, Guven Future Health Technologies INC, GESEME 1996 SL, UNIVERSITAT DE VALENCIA, KEMIJSKI INSTITUT, Smart EpiGenetX SRL, ACCENT PRO 2000 s.r.l., REPADO LOGISMIKOTECHNIKI-IPIRESIESEREYNAS KAI ANAPTIXIS EPE, dq technologies AG, Rhino Health Ltd, Innoplexus, LASER CONSULT MUSZAKI-TUDOMANYOS ES GAZDASAGI TANACSADO KORLATOLT FELELOSSEGU TARSASAG, EXO LAB ITALIA S.R.L., AGECARE (CYPRUS) LTD, FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA, INTERSPREAD GMBH, BCN HEALTH ECONOMICS & OUTCOMES RESEARCH S.L., AGENCIA PUBLICA EMPRESARIAL SANITARIA COSTA DEL SOL, FUNDACION PRIVADA HOSPITAL ASIL DEGRANOLLERS, SOM INNOVATION BIOTECH SA, ARTIFICIAL INTELLIGENCE EXPERT SRL, POLYQUANT GMBH, DYNAMEDICS S.R.L., Kelvin Health Inc., Medical Physics Unit - Second department of Radiology MEDICAL SCHOOL - ATHENS UNIVERSITY, UNIVERZITA PAVLA JOZEFA SAFARIKA V KOSICIACH, EDELWEISS CONNECT GMBH, UNIVERSIDAD DE JAEN, Let it Care, RE:LAB S.R.L., PJSC SPC DIAPROPH-MED, WE PLUS SPA, ORGANIC ELECTRONICS SAXONY MANAGEMENT GMBH, TECH2MARKET SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA, CARDET CENTRE FOR THE ADVANCEMENT OF RESEARCH & DEVELOPMENT IN EDUCATIONAL TECHNOLOGY LIMITED, Zavod za strokovno izobrazevanje in podporo inovacijam - e-Coopedu.
Website: